
Aconride MP 1mg/500mg/15mg Tablet SR
Marketer
Aconwell Pharma Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Aconride MP 1mg/500mg/15mg Tablet SR
Diabetol Trio 1mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This therapy complements diet and exercise for improved glycemic control in adult type 2 diabetes patients. It enhances insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and regimen for Diabetol Trio 1mg/500mg/15mg ER Tablets; take with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling the dose. Overdosage risks hypoglycemia. Concurrent use with other antidiabetic agents, alcohol, or skipped meals may trigger hypoglycemia; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose kidney, liver, or heart conditions to your doctor before initiating treatment. Pregnant or lactating individuals should consult their physician. Kidney function tests will be assessed prior to commencing therapy. Limit alcohol consumption as it may heighten side effect risk.
Uses of Aconride MP 1mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Aconride MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Aconride MP 1mg/500mg/15mg Extended-Release Tablet should be administered with a meal.
Common Side effects of Aconride MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Aconride MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Aconride MP 1mg/500mg/15mg Extended-Release tablets with a meal.
How Aconride MP 1mg/500mg/15mg Tablet SR works:
Aconride MP 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts triply: decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Aconride MP 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Aconride MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Aconride MP 1mg/500mg/15mg Tablet SR while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Aconride MP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Aconride MP 1mg/500mg/15mg Tablet SR is contraindicated in those with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Aconride MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Aconride MP 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Aconride MP 1mg/500mg/15mg Tablet SR :
Should you forget to take your Aconride MP 1mg/500mg/15mg Tablet SR, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Aconride MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
